GW PHARMACEUTICALS PLC Operating Income
GW PHARMACEUTICALS PLC reported Operating Income of -$21.03 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2021-05-03
- GW PHARMACEUTICALS PLC operating income (loss) for the quarter ending 2021-03-31 was -$21.03M.
- GW PHARMACEUTICALS PLC operating income (loss) for the quarter ending 2020-12-31 was -$22.81M.
- GW PHARMACEUTICALS PLC operating income (loss) for the quarter ending 2020-09-30 was -$12.72M.
- GW PHARMACEUTICALS PLC operating income (loss) for the quarter ending 2020-06-30 was -$9.04M.
- GW PHARMACEUTICALS PLC operating income (loss) for fiscal 2020 was -$51.77M.
- GW PHARMACEUTICALS PLC operating income (loss) for fiscal 2019 was -$118.42M.
- GW PHARMACEUTICALS PLC operating income (loss) for fiscal 2018 was -$288.80M.
- GW PHARMACEUTICALS PLC operating income (loss) for fiscal 2017 was -$166.16M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$21.03M 10-Q · filed 2021-05-03 | -$43.84M derived: sum of 2 quarters · filed 2021-05-03 | -$56.56M derived: sum of 3 quarters · filed 2021-05-03 | -$65.60M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-12-31 | -$22.81M 10-K · filed 2021-02-26 | -$35.53M derived: sum of 2 quarters · filed 2021-02-26 | -$44.57M derived: sum of 3 quarters · filed 2021-02-26 | -$51.77M 10-K · filed 2021-02-26 |
| 2020-09-30 | -$12.72M 10-K · filed 2021-02-26 | -$21.76M derived: sum of 2 quarters · filed 2021-02-26 | -$28.95M 10-Q · filed 2020-11-05 | -$49.06M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-06-30 | -$9.04M 10-K · filed 2021-02-26 | -$16.23M 10-Q · filed 2020-08-07 | -$36.34M derived: sum of 3 quarters · filed 2021-05-03 | -$54.00M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-03-31 | -$7.19M 10-Q · filed 2021-05-03 | -$27.30M derived: sum of 2 quarters · filed 2021-05-03 | -$44.96M derived: sum of 3 quarters · filed 2021-05-03 | -$74.28M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | -$20.11M 10-K · filed 2021-02-26 | -$37.77M derived: sum of 2 quarters · filed 2021-02-26 | -$67.09M derived: sum of 3 quarters · filed 2021-02-26 | -$118.42M 10-K · filed 2021-02-26 |
| 2019-09-30 | -$17.66M 10-K · filed 2021-02-26 | -$46.98M derived: sum of 2 quarters · filed 2021-02-26 | -$98.32M 10-Q · filed 2020-11-05 | -$171.66M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | -$29.32M 10-K · filed 2021-02-26 | -$80.66M 10-Q · filed 2020-08-07 | -$154.00M derived: sum of 3 quarters · filed 2021-02-26 | -$234.61M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$51.34M 10-K · filed 2021-02-26 | -$124.68M derived: sum of 2 quarters · filed 2021-02-26 | -$205.29M derived: sum of 3 quarters · filed 2021-02-26 | -$286.69M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$73.34M 10-K · filed 2021-02-26 | -$153.95M derived: sum of 2 quarters · filed 2021-02-26 | -$235.36M derived: sum of 3 quarters · filed 2021-02-26 | -$303.60M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-09-30 | -$80.61M 10-K · filed 2020-02-27 | -$162.01M derived: sum of 2 quarters · filed 2020-02-27 | -$230.25M 10-Q · filed 2019-11-06 | -$288.80M 10-K · filed 2021-02-26 |
| 2018-06-30 | -$81.41M 10-K · filed 2020-02-27 | -$149.65M 10-Q · filed 2019-08-07 | -$208.20M derived: sum of 3 quarters · filed 2021-02-26 | -$256.61M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-03-31 | -$68.24M 10-K · filed 2020-02-27 | -$126.79M derived: sum of 2 quarters · filed 2021-02-26 | -$175.20M derived: sum of 3 quarters · filed 2021-02-26 | -$218.23M derived: sum of 4 quarters · filed 2021-02-26 |
| 2017-12-31 | -$58.55M 10-K · filed 2021-02-26 | -$106.96M derived: sum of 2 quarters · filed 2021-02-26 | -$149.99M derived: sum of 3 quarters · filed 2021-02-26 | -$188.91M derived: sum of 4 quarters · filed 2021-02-26 |
| 2017-09-30 | -$48.41M 10-KT · filed 2019-02-28 | -$91.44M derived: sum of 2 quarters · filed 2019-02-28 | -$130.36M derived: sum of 3 quarters · filed 2019-02-28 | -$166.16M 10-K · filed 2020-02-27 |
| 2017-06-30 | -$43.02M 10-KT · filed 2019-02-28 | -$81.95M derived: sum of 2 quarters · filed 2019-02-28 | -$117.75M derived: sum of 3 quarters · filed 2019-02-28 | |
| 2017-03-31 | -$38.92M 10-KT · filed 2019-02-28 | -$74.72M derived: sum of 2 quarters · filed 2019-02-28 | ||
| 2016-12-31 | -$35.80M 10-KT · filed 2019-02-28 | |||
| 2016-09-30 | -$128.65M 10-KT · filed 2019-02-28 |